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Snail augments fatty acid oxidation by suppression of
mitochondrial ACC2 during cancer progression
Ji Hye Yang1,*, Nam Hee Kim1,* , Jun Seop Yun1, Eunae Sandra Cho1 , Yong Hoon Cha2, Sue Bean Cho1,
Seon-Hyeong Lee3, So Young Cha1, Soo-Youl Kim3, Jiwon Choi1, Tin-Tin Manh Nguyen4 , Sunghyouk Park4,
Hyun Sil Kim1 , Jong In Yook1
Despite the importance of mitochondrial fatty acid oxidation
(FAO) in cancer metabolism, the biological mechanisms respon-
sible for the FAO in cancer and therapeutic intervention based on
catabolic metabolism are not well defined. In this study, we
observe that Snail (SNAI1), a key transcriptional repressor of
epithelial–mesenchymal transition, enhances catabolic FAO,
allowing pro-survival of breast cancer cells in a starved envi-
ronment. Mechanistically, Snail suppresses mitochondrial ACC2
(ACACB) by binding to a series of E-boxes located in its proximal
promoter, resulting in decreased malonyl-CoA level. Malonyl-CoA
being a well-known endogenous inhibitor of fatty acid trans-
porter carnitine palmitoyltransferase 1 (CPT1), the suppression of
ACC2 by Snail activates CPT1-dependent FAO, generating ATP and
decreasing NADPH consumption. Importantly, combinatorial
pharmacologic inhibition of pentose phosphate pathway and FAO
with clinically available drugs efficiently reverts Snail-mediated
metabolic reprogramming and suppresses in vivo metastatic
progression of breast cancer cells. Our observations provide not
only a mechanistic link between epithelial–mesenchymal transi-
tion and catabolic rewiring but also a novel catabolism-based
therapeutic approach for inhibition of cancer progression.
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Introduction
During the natural history of human solid cancer, cancer cells re-
peatedly encounter ametabolic-starvedmicroenvironment which has
to be overcome for successful cancer progression (Aktipis et al, 2013).
Although glucose is largely regarded as a major source of anabolic
cancer cell metabolism, aerobic glycolysis is inefficient in providing
adenosine 59-triphosphate (ATP) (Vander Heiden et al, 2009). Inter-
estingly, quantitative metabolomics analysis from clinical samples
have revealed that solid cancer tissue exhibits extremely low glucose
levels due to the limited distance of glucose diffusion from functional
tumor blood vessels (Walenta et al, 2003; Hirayama et al, 2009).
Nonetheless, ATP levels in the clinical samples were well maintained
in the glucose-starved tumor microenvironment (Walenta et al, 2003;
Hirayama et al, 2009), suggesting that essential ATP may be generated
from something other than glucose. During metastatic cancer pro-
gression, matrix-detached cancer cells also encounter ATP defi-
ciency and oxidative stress due to loss of glucose transport (Schafer
et al, 2009). In these starved conditions, therefore, ATP, mainly from
oxidative phosphorylation, as well as NADPH for reductive bio-
synthesis, are essential metabolites required for overcoming
metabolic stress and for successful cancer progression, although
catabolic reprogramming by oncogenic signaling is not fully
understood.
Fatty acid metabolism consists of the anabolic process of fatty
acid synthesis (FAS) under nourished condition and the catabolic
process of fatty acid oxidation (FAO) in starved environment (Foster,
2012). The mutually exclusive FAS and FAO are reciprocally de-
pendent on nutritional status, acetyl-coenzyme A carboxylases
(ACCs) playing crucial roles in such reciprocal fatty acid metabolism
(Foster, 2012; Jeon et al, 2012). In particular, mitochondrial ACC2
determines the switch between FAS and FAO by catalyzing the
carboxylation of acetyl-CoA to produce malonyl-CoA, a potent
endogenous inhibitor of carnitine palmitoyltransferase 1 (CPT1) (Qu
et al, 2016). Because CPT1 is a rate-limiting enzyme of FAO re-
sponsible for acyl-carnitine transport into the mitochondria, ACC2
(acetyl-coA carboxylase beta, ACACB) activity and abundance are
tightly controlled in many tissues, including cancer cells. The AMPK
(59 AMP-activated protein kinase) is a well-known regulator which
suppresses ACC enzymatic activity, resulting in ATP and NADPH
homeostasis (Jeon et al, 2012). Although the importance of FAO in
metastatic progression in human cancer has recently been re-
ported (Lee et al, 2019), the upstream regulators and their func-
tional relevance in cancer progression are not fully understood.
1Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Korea 2Department of Oral and Maxillofacial Surgery, Yonsei
University College of Dentistry, Seoul, Korea 3Tumor Microenvironment Research Branch, National Cancer Center, Ilsan, Korea 4Natural Product Research Institute,
College of Pharmacy, Seoul National University, Seoul, Korea
Correspondence: jiyook@yuhs.ac; khs@yuhs.ac
*Ji Hye Yang and Nam Hee Kim contributed equally to this work
© 2020 Yang et al. https://doi.org/10.26508/lsa.202000683 vol 3 | no 7 | e202000683 1 of 14
Snail is a transcriptional repressor whose aberrant expression
has been closely linked to cancer cell epithelial–mesenchymal
transition (EMT) and cancer progression (Cano et al, 2000). Major
oncogenic pathways, such as Wnt oncogene and p53 tumor sup-
pressor, modulate Snail activities (Yook et al, 2006; Kim et al, 2011),
suggesting that transcriptional repression by Snail plays a key role
during cancer progression. Whereas earlier studies have reinforced
phenotypic conversion and migratory potential during EMT, recent
evidence indicates that EMT of cancer cells is also involved in
metabolic reprogramming of cancer cells as well as in therapeutic
resistance and cancer cell stemness (Vega et al, 2004; Kim et al, 2017).
Recently, we have reported that Snail suppresses glycolytic activity
via suppression of PFK-1 in cancer cells, resulting in glucose reflux
toward the pentose phosphate pathway (PPP) andNADPH generation
(Kim et al, 2017). The role of Snail in promoting cancer cell survival
under metabolic starvation is evident; the mechanism by which Snail
contributes to catabolic ATP generation under starved condition
remains unclear. In this study, we found that ACC2 transcript
abundance was globally suppressed in many types of human cancer
samples compared with adjacent normal tissue. Snail augments FAO,
providing essential ATP via transcriptional suppression of mito-
chondrial ACC2 followed by increased mitochondrial CPT1 activity.
Interestingly, pharmacological combinatorial inhibition of PPP and
FAO with clinically available drugs successfully interrupts Snail-
mediated metabolic reprogramming and metastatic progression in
vivo. Our observations provide not only themechanistic link between
Snail-EMT program and catabolic rewiring of cancer cells but also a
pharmacologic strategy for breast cancer using metabolic drugs.
Results
Snail regulates ATP level via FAO under glucose-starved condition
Snail potentiates cancer cell survival under metabolic stress by
activation of PPP and subsequent NADPH generation (Kim et al, 2017).
Consistently, knockdown of Snail significantly decreased clonogenic
potential in glucose-starved breast cancer cells, whereas over-
expression of Snail had the opposite effect (Figs 1A and S1A). Because
ATP together with NADPH is essential to cancer cell survival under
starved condition, we next measured ATP levels in breast cancer cells
after knockdown of Snail. Interestingly, loss of Snail significantly
decreased ATP levels, particularly in glucose-starved condition
compared with nourished culture condition (Figs 1B and S1B), and
inducible expression of Snail significantly augmented ATP levels
without glucose (Fig S1C). These results suggest that Snail plays an
important role in ATP generation under starved condition in breast
cancer cells.
Although ATP can originate from many sources in the metabolic
circuit, mitochondrial FAO is the most efficient process for gen-
erating ATP, especially in glucose-starved condition, and CPT1 is the
gatekeeper of the FAO. To obtain direct evidence that the ATP is
generated from fatty acid rather than glucose, we administered
palmitate–BSA conjugate as a mitochondrial FAO substrate to
breast cancer cells in a glucose-starved environment. Interestingly,
palmitate supplement was sufficient to recover ATP levels without
glucose and a CPT1 inhibitor etomoxir (ETX) largely blocked palmitate-
derived ATP recovery (Fig 1C), indicating that mitochondrial FAO plays
an important role in ATP homeostasis under starved condition. Given
the effect of Snail on ATP level, we next analyzed FAO via the in-
corporation of 13C16-palmitate to tricarboxylic acid (TCA) cycle inter-
mediates according to the Snail abundance (Veglia et al, 2019). Indeed,
incorporation of carbons from FAO to downstream metabolites such
as aspartate, malate, and fumarate decreased in Snail knockdown
cells as shown by the levels of their M+2 isotopomers (Fig 1D). These
results support that Snail plays an important role in ATP homeostasis
via FAO in a starved microenvironment.
During mitochondrial FAO, acyl-CoA dehydrogenases (ACADVL
and ACADM) and hydroxyacyl-CoA dehydrogenase (HADHA) catalyze
the serial steps of the fatty acid β-oxidation pathway. Examining
those enzymatic activities under glucose-starved condition, we
found that loss of Snail significantly suppressed FAO enzymatic
activities, whereas its overexpression increased those activities in
breast cancer cells (Figs 1E and S1D), supporting that Snail abun-
dance is closely correlated with mitochondrial FAO activity.
For FAO in the mitochondrial matrix, the long-chain acyl-CoA is
converted to acyl carnitine by CPT1 as a rate-limiting step in FAO on
the outer mitochondrial membrane, the acyl carnitine then being
transported across the mitochondrial membrane (Qu et al, 2016).
Given the role of Snail in FAO, we next explored the CPT1 activity
based on Snail abundance in breast cancer cells. Indeed, Snail
abundance due to shRNA or overexpression was tightly correlated
with CPT1 activity in breast cancer cells (Figs 1F and S1E). The ETX is
an irreversible inhibitor of CPT1 and is a clinically available drug for
the treatment of type II diabetes and heart failure (Kruszynska &
Sherratt, 1987). Regardless of multiple off-target effects, ETX ef-
fectively inhibits CPT1 activity as well as depletes intracellular CoA
level (Divakiaruni et al, 2018). When we administered ETX in con-
junction with induction of Snail, the ETX largely rescued ATP and
NADPH levels in breast cancer cells while increasing cell death
under glucose-starved condition (Fig 1G). The ETX also suppressed
oxygen consumption in breast cancer cells (Figs 1H and S1F). Al-
though CPT1 activity can be regulated at various levels, malonyl-CoA
catalyzed by ACC2 is a well-known potent inhibitor of CPT1, con-
stituting a reciprocal control between FAO and FAS (McGarry et al,
1978; Foster, 2012). When we examined malonyl-CoA level quanti-
tatively based on Snail abundance, we found that knockdown of Snail
increased malonyl-CoA levels, whereas overexpression of Snail de-
creased the levels (Figs 1I and S1G). Given the key role of malonyl-CoA
in reciprocal switching between FAS and FAO, Snail suppressed FAS in
the 3T3-L1 system (Fig S1H). Taken together, these findings indicate
that Snail augments FAO by suppressingmalonyl-CoA abundance and
subsequently relieving the malonyl-CoA–mediated inhibition of CPT1.
To explore the mechanistic link between Snail and FAO, we next
hypothesized that Snail suppressesmalonyl-CoA production and then
increases FAO by suppression of ACC (Fig 1J).
ACC2 is a target of Snail repressor in human cancer
In human and other mammals, two ACC isoforms exist, namely, ACC1
(ACACA) and ACC2 (ACACB). The ACC1 is mainly expressed in lipo-
genic tissues and catalyzes the committed step in the biosynthesis
of long-chain fatty acid. In contrast, ACC2 is localized at the
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mitochondrial outer membrane and regulates FAO with its malonyl-
CoA products (Jeon et al, 2012). Despite the importance of cancer cell
metabolism, differential expression of ACC isoforms in human
cancer is not clearly understood. Therefore, we next examined
differential transcript abundance of ACC1 and ACC2 in clinical
cancer samples. For differential expression analysis, we have
collected public data files on The Cancer Genome Atlas (TCGA)
from many types of human cancer, including normal control
samples. Interestingly, mitochondrial ACC2 transcript abundance
was significantly suppressed in all types of human solid cancer
comparedwith normal tissue sample, whereas cytosolic ACC1 occurred
equivalently in normal and cancer tissues (Fig 2A). These results
suggest that metabolic reprogramming by transcriptional sup-
pression of mitochondrial ACC2 plays an important role in the
pathophysiology of human cancer. To assess potential association
between Snail and ACC2, we further analyzed the transcript levels of
those genes in breast cancer TCGA according to breast cancer
subtypes and p53 tumor suppressor status. We found that (1) ACC2
Figure 1. Snail augments ATP levels via fatty acid metabolism promoting cancer cell survival under glucose starvation.
(A) Clonogenic survival assay of cancer cells following glucose starvation as described in the Materials and Methods section (left). Colonies of more than 50 cells were
counted after crystal violet staining (right). Data are expressed as means and SD. The double asterisks denote P < 0.01, one asterisk denoting P < 0.05 (n = 5, means ± SD, t
tests). (B) The cancer cells expressing control-shRNA or Snail-shRNA were incubated in the presence (Glc+) or absence (Glc−) of glucose for 4 h, and the relative ATP levels
were measured (n = 3, means ± SD, t tests). (C) The breast cancer cells in the absence of glucose (Glc−) were treated with BSA-Palmitate (100 μM) in combination with
DMSO control or ETX (100 μM) for 4 h, and the relative ATP levels were measured (n = 3, means ± SD, t tests). (D) The MDA-MB-231 cells expressing control-shRNA or Snail-
shRNA were treated with 13C-palmitate (100 μM) in the absence of glucose for 4 h. Mass isotopomer distribution of [U-13C]-palmitate–derived carbon into some TCA
metabolites was determined by LC–MS. Filled blue circles represent 13C atoms derived from [U-13C]-palmitate (*P < 0.05, **P < 0.01, ***P < 0.001, t tests). (E) The enzymatic
activities of ACADVL, ACADM, and HADHA in breast cancer cells expressing shRNA for control (shControl) or Snail (shSnail) were measured under glucose-starved
condition (0.5 mM glucose, n = 3, means ± SD, t tests). (F) The CPT1 activities of breast cancer cells expressing shRNA for control (shControl) or Snail (shSnail) under glucose-
starved condition were measured (0.5 mM glucose, n = 3, means ± SD, t tests). (G) Snail was induced by treatment of doxycycline (Dox) for 48 h and ATP (left), NADPH
(middle), and cell death (right) in starved condition were measured in combination with CPT1 inhibitor etomoxir (ETX, 100 μM, n = 3, means ± SD, t tests). (H)Mitochondrial
oxygen consumption rate (OCR) in Tet-inducible Snail in combination with ETX (n = 3, means ± SD, t tests). (I) Malonyl-CoA abundances in breast cancer cells expressing
shRNA for control (shControl) or Snail (shSnail) were measured (n = 3, means ± SD, t tests). (J) A schematic diagram depicting a potential mechanism by which the Snail
regulates fatty acid oxidation (FAO).
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and Snail are inversely correlated in breast cancer tissue, (2) ACC2
and Snail transcript abundance were closely related to p53 status in
clinical samples, and (3) ACC2 was down-regulated in triple-
negative breast cancer and ERBB2-amplified subtypes (Fig S2),
suggesting that Snail and ACC2 are specifically associated with
breast cancer subtypes and p53 status.
Given our notion regarding the critical function of Snail repressor
in FAO, we next examined whether ACC2 is a downstream target of
Snail repressor. When we knocked down endogenous Snail and
evaluated the ACC2 abundance, the transcripts and protein
abundance of ACC2 were consistently increased by loss of Snail,
whereas ACC1 transcript levels were minimally affected (Figs 2B and
Figure 2. Transcript abundance of mitochondrial ACC2 is suppressed in human cancer samples as a target of Snail repressor.
(A) ACC2 (ACACB), but not ACC1 (ACACA), transcript abundance in tumor tissue (red) was suppressed compared with adjacent normal tissue (blue) in various cancer
types. The Cancer Genome Atlas dataset included breast cancer (BRCA), colorectal adenocarcinoma (COADREAD), head and neck squamous cell carcinoma (HNSC), pan-
kidney cohort (KIPAN), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD),
stomach adenocarcinoma (STAD), and thyroid carcinoma (THCA). The adjusted P-value of various cancer types were determined by the false discovery rates (FDRs)
(Benjamini–Hochberg) method (right panel). (B) Relative transcript (left) and protein (right) abundance of ACC2 after knockdown of Snail (shSnail) in breast cancer cells (n
= 3, means ± SD, t tests). (C) Schematic diagram showing positions of potential Snail-binding canonical E-boxes on the ACC2 proximal promoter region and its reporter
constructs of wild type or mutant E-boxes. (D) Fold increase of reporter activities in combination with wild type or mutated ACC2 promoter following shRNA-mediated
Snail knockdown compared with each control shRNA in breast cancer cells (n = 3, means ± SD, t tests). (E) ChIp-enriched DNA was determined by qRT-PCR using specific
primers complementary to the promoter region containing E-box of ACC2 and a positive control PFKP (n = 3, means ± SD, t tests).
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S3A). Conversely, overexpression of Snail suppressed transcripts
and protein abundance of ACC2 (Fig S3B), suggesting that ACC2 may
be a downstream target of Snail repressor, similar to E-cadherin
and phosphofructokinase, platelet (PFKP) (Cano et al, 2000; Kim
et al, 2017). Indeed, the proximal ACC2 promoter region harbors two
Snail-binding canonical E-boxes (CAGGTG), and we could clone the
promoter region of ACC2 into the firefly luciferase reporter vector
with mutations of the putative Snail-binding sites individually or in
combination (Fig 2C). The ACC2 reporter activity increased when we
silenced endogenous Snail in breast cancer cells, whereas specific
mutation of predicted binding sites relieved the ability of Snail to
suppress reporter activity (Fig 2D). Overexpression of Snail sup-
pressed promoter activity in an E-box–dependent manner (Fig S3C).
Upon chromatin immunoprecipitation (ChIP) assay to determine
whether Snail locates a repressor complex in ACC2 promoter, we
found that a DNA fragment containing E-boxes from ACC2 can be
amplified from the immunoprecipitated genomic DNA samples
from antibody of endogenous Snail (Fig 2E), indicating that ACC2 is a
transcriptional target of EMT inducer Snail.
Suppression of ACC2 promotes FAO, leading to cancer
pro-survival
Malonyl-CoA catalyzed by ACC2 is a potent endogenous inhibitor of
CPT1, resulting in suppression of FAO (Foster, 2012). Given the Snail-
dependent malonyl-CoA level and ACC2 suppression, we next ex-
amined the roles of ACC2 in FAO in terms of cancer cell pro-survival.
Consistent with the well-known role of ACC2, themalonyl-CoA levels
were closely correlated with ACC2 abundance in breast cancer cells
(Figs 3A and S4A). As the malonyl-CoA–mediated CPT1 regulatory
axis has been firmly established (Foster, 2004, 2012), CPT1 activities
followed by FAO activities are known to be inversely correlated with
ACC2 abundance and malonyl-CoA levels (Figs 3B and C and S4B).
Suppression of ACC2 with two independent set of shRNA largely
augmented ATP levels in MCF-7 and MDA-MB-231 cells, especially
under glucose starvation (Figs 3D and S4C), whereas overexpression
of ACC2 had the opposite effect (Fig S4D). The anabolic FAS and
catabolic FAO are mutually exclusive, FAS mainly consuming in-
tracellular NADPH in cells (Fan et al, 2014). Indeed, the fall of
malonyl-CoA and activation of FAO by knockdown of ACC2 increased
NADPH level in breast cancer cells (Fig 3E), indicating that ACC2
abundance is critically important for NADPH homeostasis as well as
for the production of cellular ATP. Collectively, loss of ACC2
abundance in human cancer largely increased pro-survival func-
tion and clonogenic capacity induced by glucose starvation (Fig 3F
and G), whereas overexpression of ACC2 largely attenuated clo-
nogenic potential in vitro (Fig S4E). To examine whether metabolic
reprogramming regulated by ACC2 plays a role in tumor initiation
and metastatic progression, we next performed an in vivo exper-
iment. Indeed, induction of ACC2 in MDA-MB-231 cells largely
suppressed the in vivo tumor initiation (Fig 3H). When these cells
were injected into tail vein, increased ACC2 abundance suppressed
the lung metastatic potential of MDA-MB-231-luc-D3H2LN cells
phenocoping the loss of Snail (Fig 3I) (Ye et al, 2015; Ni et al, 2016;
Kim et al, 2017). As anti-oxidative NADPH level is critically important
for chemotherapeutic resistance (Kim et al, 2017), knockdown of
ACC2 conferred therapeutic resistance of breast cancer cells
against paclitaxel (Fig S4F). To further determine the potential
importance of ACC2 in a clinical setting, we analyzed the clinical
outcomes in TCGA breast cancer samples. We noted an inverse
relationship between ACC2 and overall survival in patients having
wild-type, but not mutant p53 status (Fig 3J). These results support
the importance of ACC2 transcript abundance in cancer initiation
and progression, with therapeutic implications.
Role of the Snail-ACC2 axis in metabolic reprogramming
Given the ability of Snail to potentiate cancer cell survival with
increased ATP level, we sought to determine whether ACC2 con-
stitutes a key element in the catabolic rewiring by Snail. To validate
the Snail-ACC2 regulatory axis, we designed an experimental sys-
tem in which regulation of ACC2 could rescue metabolic reprog-
ramming of ATP production and FAO by Snail. Indeed, falling ATP
levels due to loss of Snail, especially in glucose-starved condition,
were rescued by knockdown of ACC2 (Fig 4A). Conversely, over-
expression of ACC2-attenuated ATP levels increased by Snail (Fig
S5A). Furthermore, ACC2 abundance was critical for FAO enzymatic
activities regulated by Snail (Figs 4B and S5B). Investigating the pro-
survival function of ACC2 under metabolic stress, we found sup-
pression of ACC2 sufficiently rescued clonogenic potential due to
loss of Snail (Fig 4C), whereas overexpression of ACC2 had the
opposite effect (Fig S5C). Consistent with previous observations
(Jeon et al, 2012; Kim et al, 2017), knockdown of Snail decreased
NADPH levels and loss of ACC2 rescued the role of Snail repressor,
whereas overexpression of ACC2 did the opposite (Figs 4D and S5D).
These observations indicate that transcriptional suppression of
ACC2 in human cancer plays a critical role during Snail-mediated
catabolic metabolism of NADPH and ATP.
Pharmacological inhibition of PPP and CPT1 attenuates cancer
progression
We have recently shown that Snail increases PPP flux via sup-
pression of PFKP, resulting in NADPH production to potentiate
cancer cell survival under metabolic stress (Kim et al, 2017). In this
study, we further report that Snail augments FAO by suppression of
ACC2, not only providing essential ATP under glucose-starved
condition but also suppressing NADPH consumption. Given the
ability of Snail to increase FAO via suppression of ACC2 and sub-
sequent activation of CPT1, we hypothesized a critical role of Snail in
providing catabolic pro-survival function of cancer cells through
NADPH homeostasis and ATP generation (Fig 5A). Because glucose-
6-phosphate dehydrogenase (G6PD) is a gatekeeper of PPP, our
observations suggest that G6PD and CPT1 can be used to thera-
peutically target the metabolic reliance of human cancer on PPP
and FAO. To test this notion, we interrupted Snail-mediated met-
abolic reprogramming by overexpression of ACC2 and knocked
down G6PD, then measured ATP levels. Indeed, the intervention in
FAO together with PPP significantly depleted ATP levels in breast
cancer cells (Fig 5B), supporting the notion that metabolic inhi-
bition of PPP and FAO constitutes a novel therapeutic approach for
human cancer.
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Figure 3. Suppression of ACC2 increases CPT1 activity and fatty acid oxidation, providing pro-survival under metabolic stress.
(A) Relative malonyl-CoA abundance according to ACC2 knockdown (left). ACC2 abundance was determined by immunoblot analysis after transduction of inducible
shRNA (right). The double asterisks denote P < 0.01, one asterisk denoting P < 0.05 (n = 3, means ± SD, t tests). (B) Fatty acid oxidation enzymatic activities under glucose-
starved condition (0.5 mM) were determined after inducible knockdown (Dox+) of ACC2 compared with control (Dox−). (C) Knockdown of ACC2 increases CPT1 activity in
breast cancer cells (n = 3, means ± SD, t tests). (D) ACC2 was knocked down by treatment of doxycycline (Dox) for 48 h, and ATP levels were measured with glucose (Glc+)
or glucose-starved (Glc−) condition (n = 3, means ± SD, t tests). (E) ACC2 was knocked down by treatment of doxycycline (Dox) for 48 h, and NADP+/NADPH ratio was
determined (n = 3, means ± SD, t tests). (F) Cells were cultured under glucose-starved condition for a 48-h period, and cell death was quantitated by trypan blue exclusion
assay (n = 3, means ± SD, t tests). (G) Clonogenic survival assay of cancer cells after glucose starvation for a 72-h period. Colonies of more than 50 cells were counted after
crystal violet staining (n = 5, means ± SD, t tests). (H)MDA-MB-231 cells (1 × 106) expressing dsRed (n = 3) or ACC2 (n = 3) were injected orthotopically into the mammary fat
pads of nude mice. Tumor initiation and volume were monitored biweekly. Results are shown as means and SEM. Asterisks, P < 0.01 compared with the control by
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For a pharmaceutical approach against these metabolic targets,
we chose dehydroepiandrosterone (DHEA) and etomoxir (ETX) as
clinically available G6PD and CPT1 inhibitors, respectively. Inter-
estingly, DHEA or ETX alone minimally affected NADPH and ATP
levels in physiologic glucose concentration, whereas in combina-
tion, they significantly suppressed NADPH and ATP levels in breast
cancer cells (Fig 6A). Examining real-time cell growth, we found the
combination of DHEA and ETX significantly suppressed cell prolifer-
ation under physiologic glucose condition (Fig 6B). Examining clo-
nogenic potential under metabolic stress, the dual pharmacological
inhibition synergistically and dramatically suppressed the clonogenic
potential of breast cancer cells (Fig 6C); although clinically available,
DHEA is an uncompetitive G6PD inhibitor. To support our combina-
torial approach, we next used CB83 as a novel selective inhibitor of
G6PD (Preuss et al, 2013). To predict the binding mode for CB83 to the
substrate binding site of hG6PD, a molecular docking simulation was
performed. Docking pose analyses revealed that the benzene ring of
the CB83 is embedded in a hydrophobic pocket, contributing to the
complex formation; moreover, the sulfonamide and hydroxyl group
present in the CB83 additionally formed hydrogen bonds with the
lysine or aspartic acid side chain: Lys205, Asp258, and Lys360 (Fig S6A).
These results indicate that the CB83 compound strongly interacts with
the NADP+ substrate-binding site of hG6PD and show that the docked
pose of this compound adopts conformations similar to those ob-
served in the crystal structure of G6P-bound hG6PD (Kotaka et al,
2005). Indeed, CB83 combined with ETX had similar metabolic effects
in terms of NADPH, ATP, cell growth, and clonogenic potential in breast
cancer cells (Fig S6B–D). These results indicate that a pharmaceutical
approach against PPP and FAO could efficiently intervene inmetabolic
reprogramming during Snail-mediated EMT.
Figure 4. Snail-ACC2 axis controls fatty acid oxidation and NADPH homeostasis.
(A) Relative ATP level in breast cancer cells transduced with shRNA control (shControl) or with Snail shRNA (shSnail). ACC2 was knocked down by treatment with
doxycycline (Dox+) for 48 h in Snail shRNA cells under either nourished condition (Glc+) or glucose-starved condition (Glc−). The double asterisks denote P < 0.01, one
asterisk denoting P < 0.05 (n = 3, means ± SD, t tests). (B, C, D) Inducible knockdown of ACC2 rescued metabolic reprogramming by lack of Snail. The fatty acid oxidation
activity (B), clonogenic capacity (C), and NADP+/NADPH ratio (D) after glucose starvation were measured. Data are means ± SD from n = 3 for (B, C), from n = 5 (D).
Mann–Whitney test. (I) The MDA-MB-231-luc-D3H2LN cells (5 × 105 cells) either of control (dsRed, n = 3) or of ACC2 overexpression (ACC2, n = 3) were injected
intravenously into tail veins of immunodeficient mice. The number of lung metastatic nodules at day 28 was counted under microscopic examination (left). Whole-field
images of representative lungs showed themedian value for each group. Statistical significance was determined byMann–Whitney test (right). Arrows indicate metastatic
tumor foci in mouse lung. Scale bar, 2 mm. (J) Kaplan–Meier survival graphs for all patients with breast cancer (left) or for those with wild-type p53 (middle) or p53
mutant (right) cancers, on the basis of ACC2 mRNA transcript abundance at an optimal threshold indicated by percentile numbers. Samples with decreased ACC2
expression are represented with blue lines. A log-rank test was used to calculate statistical significances.
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To test the in vivo therapeutic potential of this combined phar-
maceutical approach, we next used a well-established xenograft
model with MDA-MB-231 breast cancer cells. Although DHEA or ETX
alone minimally suppressed in vivo tumor growth, their combi-
nation significantly suppressed tumorigenic potential as well as
tumor growth (Fig 6D). We found no obvious systemic toxicity with
combined pharmaceutical administration, including body weight
(Fig S6E). Last, we further assessed the pharmacologic use of DHEA
and ETX in a lung metastasis model. Indeed, the inhibition of PPP
and CPT1 significantly suppressed the lung metastatic potential of
MDA-MB-231-luc-D3H2LN cells (Fig 6E). These results indicate that
pharmacologic inhibition of PPP and CPT1 may provide a thera-
peutic advantage for breast cancer patients.
Discussion
Whereas glycolysis, known as the Warburg effect, has been known
to constitute an important metabolic aspect of cancer cells for
several decades, aerobic glycolysis is now widely accepted as the
glucose metabolism for production of biomass, such as amino acids,
nucleotides, and fatty acids, supporting the anabolic process of cancer
cell proliferation (Vander Heiden et al, 2009; Cha et al, 2015). However,
cancer cells repeatedly face metabolic stresses in the microenvi-
ronment such as limited glucose supply during the natural history of
cancer progression (Aktipis et al, 2013). Interestingly, cancer cells in
clinical tissues maintain their ATP level despite lack of glucose from
blood vessels (Walenta et al, 2003; Hirayama et al, 2009), suggesting a
source of ATP other than aerobic glycolysis.
Anabolic FAS and catabolic FAO constitute mutually exclusive
fatty acid metabolisms determined by the conversion of acetyl-CoA
into malonyl-CoA by ACCs (Foster, 2004, 2012). Although malonyl-CoA
in FAS is mainly involved in the elongation of fatty acids via fatty acid
synthase (FASN), it also regulates CPT1 activity resulting in fatty acid
transport into mitochondria (Foster, 2004, 2012). Therefore, malonyl-
CoA levels determine the switch between FAS and FAO by inhibiting
mitochondrial CPT1, a rate-limiting step in FAO (McGarry et al, 1978;
Foster, 2004). Acetate has recently been highlighted as a source of
acetyl-CoA in human cancer (Mashimo et al, 2014; Liu et al, 2018),
although the regulatory role of acetyl-CoA on fatty acidmetabolism is
not well understood. Because the FAS largely consumes intracellular
NADPH (Fan et al, 2014), reciprocal regulation of FAS and FAO by
malonyl-CoA plays a critical role in ATP generation as well as NADPH
homeostasis. Indeed, ACC activity and abundance are tightly regu-
lated in cells, including in human cancer. For example, AMPK (AMP-
activated protein kinase) phosphorylates the ACCs, thereby inhibiting
synthesis of malonyl-CoA and subsequently activating CPT1 activity
and FAO for ATP generation (Foster, 2004). Here, we found that Snail
repressor regulates transcriptional levels of ACC2, thereby sup-
pressing malonyl-CoA and activating CPT1 activity. Moreover, transcript
abundance ofmitochondrial ACC2, but not of cytosolic ACC1, was globally
down-regulated inmany typesofhumancancer samples comparedwith
adjacent normal tissue, indicating that transcriptional repression aswell
as phosphorylation-mediated enzymatic inhibition of ACC2 comprises
important metabolic rewiring in human solid cancer.
Figure 5. Snail augments catabolic metabolism via
activation of pentose phosphate pathway and fatty
acid oxidation (FAO).
(A) A schematic diagram depicting a potential catabolic
mechanism by which the Snail regulates pentose
phosphate pathway flux and FAO activity. Open arrows
denote metabolic outcomes of catabolic metabolism
regulated by increased Snail abundance in cancer
cells. (B) Relative ATP levels (left) and immunoblot
(right) in breast cancer cells according to ACC2
expression in combination with inducible glucose-6-
phosphate dehydrogenase (G6PD) knockdown (Dox)
under physiologic glucose concentration (5.5 mM, n = 3,
means ± SD, t tests).
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FAO is the most important catabolic metabolism by which fatty
acid chains are serially shortened in the mitochondria to generate
NADH, FADH2, and acetyl-CoA (Carracedo et al, 2013). In a highly
efficient process, the complete oxidation of a C16-palmitate
molecule yields 106 molecules of ATP. Although glycolysis is largely
regarded as ametabolic source of ATP in cancer, the contribution of
FAO as a source of ATP, especially in a glucose-limited microen-
vironment, is not yet clearly understood.
Figure 6. Combined pharmacological inhibition of pentose phosphate pathway and CPT1 synergistically suppresses cancer progression.
(A) A glucose-6-phosphate dehydrogenase inhibitor DHEA (20 μg/ml) in combination with CPT1 inhibitor etomoxir (ETX, 200 μM) was treated for a 16-h period. The
NADP+/NADPH ratio (left) and ATP levels (right) were determined from breast cancer cells under physiologic glucose concentration (5.5 mM). The double asterisks denote P <
0.01, one asterisk denoting P < 0.05 (n = 3, means ± SD, t tests). (B) Live cell density of breast cancer cells after treatment of DHEA (20 μg/ml) in combination with etomoxir (ETX,
200 μM) for a 48-h period under physiologic glucose concentration (n = 5, means ± SD, t tests). (C) Clonogenic survival of breast cancer cells under glucose-deprived
condition (0.5 mM) in combination with DHEA (6.25 μg/ml) and/or etomoxir (ETX, 100 μM) followed by refreshment of normal culture medium (left). The colony number (right)
was determined by stereomicroscopic examination as described in the Materials and Methods section (n = 5, means ± SD). (D) MDA-MB-231 cells (1 × 106) were orthotopically
injected into themammary fat pads of either vehicle (n = 10), or oral administration of DHEA (100mg/kg, n = 10), or intraperitoneal administration of etomoxir (ETX, 50mg/kg,
n = 10), or a combination of DHEA and ETX (n = 9). The drugswere given five times aweek and tumor growthwasmeasured twice aweek (means ± SEM). Two asterisks denote P <
0.01 by Mann–Whitney test. (E) Lung metastasis by tail vein injection of MDA-MB-231-D3H2LN cells (5 × 105). The mice were administrated by either vehicle (n = 8), or oral
administration of DHEA (100mg/kg, n = 8), or intraperitoneal administration of etomoxir (ETX, 50mg/kg, n = 8), or a combination of DHEA and ETX (n = 8). The number of lung
metastatic nodules at day 28 was counted under microscopic examination (left), and statistical significance was determined by Mann–Whitney test. Whole-field images of
representative lungs showing median value for each group (right). Arrows indicate metastatic tumor foci in mouse lung. Scale bar, 1 mm.
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It should be noted that ATP generation is tightly connected with
NADPH homeostasis because oxidative phosphorylation in the
redox reactions inevitably produces reactive oxygen species. Thus,
generation of ATP and reductive NADPH are essential for cancer
cells to survive in a glucose-starved environment or to gain
therapeutic resistance (Ramanathan et al, 2005; Schafer et al, 2009).
While the Snail repressor has long been noted as a phenotypic EMT-
inducer, recent observations indicate that Snail-mediated EMT
comprises a wide range of cancer cell behavior, such as therapeutic
resistance and stemness (Wolf, 2014). We reported that EMT-inducer
Snail increases PPP flux by suppression of PFK-1, a gatekeeper of
glycolytic flux converting fructose 6-phosphate (F6P) into fructose
1,6-bisphosphate (F1,6BP) (Kim et al, 2017; Cho et al, 2018). In this
light, a recent report regarding Snail-mediated suppression of
fructose-1,6-bisphosphatase (FBP1) in triple-negative breast cancer
is of special interest because loss of FBP1 suppresses endergonic
gluconeogenesis from F1,6BP to F6P that is the reverse enzymatic
reaction of PFK-1 (Dong et al, 2013). It should be noted that PPP is
tightly connected and coordinated with glycolysis and that in-
hibition of the glycolytic pathway by suppression of PFK-1 or
pyruvate kinase activates PPP flux resulting in cancer progression
(Anastasiou et al, 2011; Kim et al, 2017). Given the well-known role
of bi-directional transketolase (TKT) and transaldorase (TALDO1)
interconverting glyceraldehyde-3-phosphate in glycolysis and
ribose-5-phosphate in PPP, loss of FBP1 by Snail also provides
concomitant generation of NADPH and ATP as well as a building
block in a variety of biosynthesis via nonoxidative branch of the
PPP (Berg et al, 2012; Cho et al, 2018). Therefore, the intercon-
version of glycolytic glyceraldehyde-3-phosphate/F6P and ribose-5-
phosphate explains the paradoxical suppressor function of Snail on
glycolysis and gluconeogenesis, suggesting the existence of a different
metabolic circuit according to cancer subset or oncogenic activation.
In turn, EMT-inducer Snail increases PPP-dependent glucose meta-
bolism rather than glycolytic interconversion between F6P and F1,6BP,
a major rate-limiting step in glycolysis. In this study, we show that loss
of ACC2 by Snail increases ATP and NADPH levels, resulting in pro-
survival of cancer cells under metabolic stress. However, little is
known about such catabolic metabolic reprogramming in certain
metabolic circuits and fatty acid metabolism in special contexts.
Further study is required to delineate the role of specific contexts,
such as oncogenic activation and cancer subtypes, in Snail-mediated
suppression of glycolysis or gluconeogenesis inmetabolic advantages
supporting breast cancer progression.
The Snail repressor is critically required for metastatic pro-
gression and plays a critical role in catabolic metabolism under
glucose-limited condition (Ye et al, 2015). Therefore, targeting
catabolic metabolism with clinically available drugs may provide
therapeutic options for cancer patients, especially in the advanced
stage. Recent studies have shown that CPT1 is overexpressed in
various types of human cancer, making it a metabolic target
(Camarda et al, 2016; Qu et al, 2016; Kim, 2018). Given the role of Snail
repressor in metastatic cancer progression and metabolic rewiring
to provide NADPH and ATP, we attempted combinatorial ap-
proaches to inhibit PPP and FAO. G6PD is an interesting metabolic
target for cancer therapeutics, and DHEA is widely used for PPP
inhibition (Fang et al, 2016; Cho et al, 2018). Indeed, knockdown of
G6PD or DHEA increased oxidative stress in cancer cells, resulting in
decreased migratory potential and increased susceptibility to cell
death under various stresses (Schafer et al, 2009; Fang et al, 2016;
Kim et al, 2017). Earlier epidemiological studies show that DHEA
level and its sulfated metabolite are inversely related to breast
cancer risk, suggesting a possible effect of DHEA against breast
cancer (Zumoff et al, 1981). Moreover, DHEA inhibits tumor devel-
opment and progression in many types of animal models (Boccuzzi
et al, 1992; Di Monaco et al, 1997), although the clinical effectiveness
of DHEA alone is limited because of a relatively high IC50 level to
control G6PD activity and subsequent high oral doses.
The ETX is an irreversible small molecule inhibitor of CPT1 on the
outer face of the inner mitochondrial membrane (Kruszynska &
Sherratt, 1987). Although the ETX has been developed for type 2
diabetes and heart failure through clinical trials (Fillmore &
Lopaschuk, 2013), it is now receiving attention as a potential
repositioned therapeutic because FAO has emerged as a metabolic
target of cancer, regardless of its off-target effect (Divakaruni et al,
2018; Lee et al, 2019). Given the reciprocal balance between FAS and
FAOmediated by malonyl-CoA (Foster, 2004, 2012), inhibition of FAO
induces ATP depletion as well as impairs NADPH homeostasis (Jeon
et al, 2012; Fan et al, 2014). In this study, we provide experimental
evidence that combinatory metabolic inhibition against FAO and
G6PD inhibition with clinically available drugs successfully sup-
presses metastatic cancer progression.
Materials and Methods
Cell culture and immunoblot analysis
MCF-7 and 293 cells obtained from ATCC were routinely cultured in
DMEM medium containing 10% FBS. MDA-MB-231 cells (a gift from G
Mills) were cultured in an RPMI1640 with 5% FBS. Mycoplasma
infection was tested regularly with a PCR-based kit (MP0040; Sigma-
Aldrich). Cell lines were authenticated as described recently (Kim
et al, 2017). The transfection was performed by Lipofectamine 2000
according to the manufacturer’s protocol (Invitrogen). For FAS
assay, 3T3-L1 preadipocytes (kindly provided by JW Kim of the
Yonsei Univeristy College of Medicine) were used. Post-confluent
3T3-L1 cells for 2 d (from “day 0”) were cultured in DMEM with 10%
FBS, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX; Sigma-Aldrich), 2
μg/ml dexamethasone (Sigma-Aldrich), and 1 μg/ml insulin
(Roche) for 2 d. After 2 d, the media were changed with fresh DMEM
including 10% FBS and 1 μg/ml insulin. This was repeated every 2 d,
adipocyte being valid for up to 8 d from the date of culture start. On
day 8, the lipid droplet formation could be confirmed by Oil Red O
staining. Tomeasure the exact content of lipid accumulation, Oil RedO
was dissolved in 100% isopropyl alcohol, and its absorbance was
detected at the 490 nmwavelength with a spectrophotometer. For the
Western blot analyses, protein extracts were prepared in Triton X-100
lysis buffer. Antibodies against Snail (3895S, mousemonoclonal L70G2,
1:2,000; Cell Signaling Technology), ACC2 (HPA006554, rabbit polyclonal,
1:1,000; Sigma-Aldrich), G6PD (sc373887, mouse monoclonal G6, 1:1,000;
Santa Cruz), Flag (F-3156, mouse monoclonal, 1:5,000; Sigma-Aldrich),
and tubulin (LF-PA0146, rabbit polyclonal, 1:5,000; AbFrontier) were
obtained from commercial vendors. Dehydroepiandrosterone (DHEA,
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CAS 53-43-0) and etomoxir (ETX, CAS 828934-41-4) were purchased
from Calbiochem and Sigma-Aldrich, respectively. CB83 (N-(4-
hydroxynaphthalen-1-yl)-2,5-dimethylbenzenesulfonamide,
C18H17NO3S, MW 327.4) was synthesized by the 4Chem Laboratory.
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated using TRIzol reagent (Invitrogen) following
the manufacturer’s protocol. The SuperScript III synthesis kit
(Invitrogen) was used to generate cDNA. qRT-PCR analysis for ACC1
and ACC2 transcripts was performed with an ABI-7300 instrument
under standard conditions and SBGR mix (n = 3). The ΔCt value
expression from each sample was calculated by normalizing with
GAPDH. Primer specificity and PCR process were verified by disso-
ciation curve after PCR reaction. The primer sequences for qRT-PCR
were 59-ctcttgaccctggctgtgtactag for ACC1 forward, 59-tgagtg
ccgtgctctggat for ACC1 reverse, 59-tccgcggctataatgaaaacag for ACC2
forward, 59-tcgtagtgggcttgctgaaa for ACC2 reverse, 59-atgggtgtg
aacccatgagaag for GAPDH forward, and 59-agttgtcatggatgaccttgg for
GAPDH reverse.
Plasmids and RNA-mediated interference
Tetracycline-inducible Snail expression vector was generated with
the pTRIPZ lentiviral system (Open Biosystems) by replacing red
fluorescent protein with Flag-tagged Snail and lentivirus-mediated
(pLL3.7-dsRed). Snail knockdown was reported recently (Kim et al,
2017). The Tet-pLKO-puro vector (#21915, obtained from Addgene)
was used for an independent set of inducible shRNA knockdown of
Snail or G6PD (Vega et al, 2004). Lentiviral ACC2 expression and
shRNA vector were kindly provided by SM Jeon (Ajoo University)
(Jeon et al, 2012). The target sequences of shRNA were 59-
gtggagctgattgtggacatt for shACC2; an independent set of siACC2 was
purchased from Santa Cruz Biotechnology.
Liquid chromatography–mass spectrometry measurement
For preparation of palmitate-BSA conjugate, sodium palimitate (1
mM, P9767; Sigma-Aldrich) in 150 mM NaCl was prewarmed and
stirred at 70°C. Then, prewarmed fatty acid–free BSA solution (0.17
mM, 6:1 molar ratio palmitate:BSA) was added to palmitate solution
and stirred for 1 h at 37°C, and the final volume adjusted to 1 mM
palmitate:0.17 mM BSA. The MDA-MB-231 cells expressing inducible
Snail-shRNA were treated with 13C-palmitate (100 μM) for 4 h, and
the cell pellets were extracted by three times of freeze–thaw cycle
using solvent system DW:MeOH:CHCl3 (1:2:2). The mixtures were
subsequently centrifuged at 14,000g at 4°C for 10 min. The sepa-
rated upper and lower layers were further evaporated by vacuum
evaporator, and the samples were kept at −80°C until further
analysis. The dried hydrophilic phase above was reconstituted in a
mixture of DW:ACN (20 μl, 1:1 vol/vol) containing [U-13C]-glutamine
as internal standard and then introduced into an liquid chroma-
tography–mass spectrometry system. Metabolites were separated
by Zic-pHilic column (150 × 2.1 mm, particle size: 5 μm;Merck) at 40°C
using Acquity UPLC Waters coupled with Q Exactive Focus Hybrid
Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scien-
tific). The mobile phases were 10 mM ammonium carbonate (A) and
ACN (B) with the gradient as follows: 20% A from 0 to 2 min, then
increasing gradually to 80% for 17 min, and kept there for 4 min. Set
20% A at 23.1 min was followed by 2 min equilibrium with a 0.15 ml/
min flow rate. The Q Exactive Focus MS system equipped with a
heated electrospray ionization (HESI-II) probe with the following
settings: sheath gas = 40 ml/min; auxiliary gas = 10 ml/min, heated
to 250°C; sweep gas = 2 ml/min; spray voltage = 2.5 kV, followed by
capillary temperature at 256°C; and S-lens RF level = 100. The
resolution was set at 70,000, and the AGC target was set at 1 × 106.
Data were acquired in negative mode, and isotopologue peaks were
extracted using Xcalibur ver. 2.8 (Thermo Fisher Scientific). The raw
data of the results can be found in Supplemental Data 1.
Metabolic analysis
The intracellular quantitation of NADPH and total NADP (NADPH
and NADP+) were measured using the colorimetric method (K347;
BioVision). The concentration of NADP+ was calculated by sub-
tracting [NADPH] from [total NADP]. Quantitative enzymatic activ-
ities of ACADVL, ACADM, and HADHA in the mitochondrial FAO
pathway were measured with a commercial colorimetric assay kit
according to the manufacturer’s protocol (ab118182; Abcam). CPT1
activity was measured with a commercial kit based on ELISA
(OKEH00404; Aviva Systems Biology). Malonyl-CoA content was
measured with a humanmalonyl-co enzyme A ELISA kit (MBS705079;
MyBioSource) according to the manufacturer’s specifications. ATP
level was measured with an ATP colorimetric assay kit (K354;
BioVision) in the absence or presence of glucose and FBS before
starting preparation of seeded cells (1 × 106) according to the
manufacturer’s instructions. The oxygen consumption rates (OCRs)
were measured using the Seahorse XF-24 instrument (Seahorse
Bioscience) under standard conditions after the addition of 1 μM
oligomycin, 0.25 μM FCCP, and 0.5 μM rotenone/antimycin A. Real-
time measurements of the OCR in pmol per minute per μg per
protein in adjusted base medium (L-glutamine 2.05 mM, D-glucose
2gL-1) were plotted over time before and after the addition of
rotenone/antimycin A to specifically measure non-mitochondrial
respiration. The difference in OCR between initial non-drug treat-
ment and after addition of rotenone/antimycin A reflects the basal
oxygen consumption by mitochondria. The OCR measurements were
normalized with protein abundance of plated cells through BCA
assay at a wavelength of 562 nm.
ACC2 promoter cloning and reporter assay
The promoter region (−594 ~ −1 from the starting codon) of ACC2 was
amplified from genomic DNA of MCF-7 cells and subcloned into
pGL3 basic vector (Promega). E-box sequence 59-CAGGTG was
mutated to 59-AAGGTA. To examine ACC2 promoter activity, the
breast cancer cells were transfected with 100 ng of reporter vectors
and 5 ng of pSV-Renilla expression vector. Luciferase and Renilla
activities were measured using the dual-luciferase reporter system
kit (Promega), the luciferase activity being normalized with Renilla
activity. The results are expressed as the averages of the ratios of
the reporter activities from triplicate experiments. For ChIP analysis,
cells were cross-linked with 1% (vol/vol) formaldehyde at room
temperature and suspended in a ChIP lysis buffer containing 10 mM
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Hepes (pH 7.9), 0.5% NP-40, 1.5 mMMgCl2, 10mM KCl, 0.5 mMDTT, and
protease inhibitor cocktail on ice (Kim et al, 2017). After centrifu-
gation, the pellets were resuspended in buffer containing 20 mM
Hepes (pH 7.9), 25% glycerol, 0.5% NP-40, 0.42 M NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, and protease inhibitors followed by extraction of
nuclear proteins. Nuclear pellets were resuspended in IP buffer (1%
Triton X-100, 2 mM EDTA, 20 mM Tris–HCl [pH 8.0], 150 mM NaCl, and
protease inhibitors) and sonicated to break chromatin into frag-
ments with an average length of 0.5–1 kb. The supernatants were
incubated overnight with anti-Snail antibody or corresponding
normal IgG. After incubation with protein G-agarose beads (Invi-
trogen) for 2 h at 4°C, the beads were extensively washed with lysis
buffer. Bound DNA–protein complexes were eluted after an over-
night incubation at 65°C in TE buffer. To amplify the ACC2 and PFKP
promoter fragments as a positive control, the following primers
were used for RT-PCR analysis: ACC2, forward 59-attgcacatgtgacctcctg,
reverse 59-cctgtagatctggggtgtca; PFKP, forward 59-ctagagcccccaacca-
gagt, reverse 59-gtgtgggcaggagcatctac. The results were normalized
relative to input activities and presented as mean ± SD from three
independent experiments.
Cell death and clonogenic survival capacity
For the glucose starvation experiments, 5 × 103 cells were plated
into six-well plates with normal culture medium a day before
starvation. The cells were washed with PBS and cultured in glucose-
free DMEM containing 10% FBS adjusted to ~0.5 mM glucose. The
MDA-MB-231 cells and MCF-7 cells were starved for 48 and 72 h,
respectively. Cell death induced by glucose starvation was mea-
sured by trypan blue exclusion assay. Separately, clonogenic sur-
vival was performed by exposing cells to glucose-starved condition
for 72 h followed by further observation in normal culture medium
for 14 d (Franken et al, 2006). After crystal violet (0.5% wt/vol)
staining, colonies of more than 50 cells were counted under a
stereomicroscope. The results of clonogenic assay are expressed as
the ratios of the number of survival colonies comparedwith control.
For clonogenic survival against paclitaxel treatment, 5 × 103 cells
were plated into six-well plates with normal culture medium 48 h
before paclitaxel treatment in the absence or presence of doxy-
cycline for inducible expression of Snail or ACC2 shRNA. The cells
were then cultured in paclitaxel-containing culture medium for 48
h followed by refreshment of normal culture medium for an ad-
ditional 10–14 d to determine clonogenic survival. The number of
colonies in five randomly chosen fields was determined under a
high power stereomicroscope. Real-time cell growth was analyzed
by JuLI Stage systems (NaoEn Teck) according to the manufacturer’s
instructions. Cell number was counted with an EVE automatic
counter (NanoEnTek).
Gene expression analysis of clinical samples
Publicly available mRNASeq data of human cancer samples in-
cluding normal tissue (>30 samples) were downloaded (https://
gdac.broadinstitute.org). The level 3 dataset (data version 2026_01_28)
included breast cancer (BRCA, 1,100 cancer samples with 112 normal
tissue samples), colorectal adenocarcinoma (COADREAD, 626 cancer
with 51 normal), head and neck squamous cell carcinoma (HNSC, 522
cancer with 44 normal), pan-kidney cohort (KIPAN, 891 cancer with 129
normal), liver hepatocellular carcinoma (LIHC, 373 cancer with 50
normal), lung adenocarcinoma (LUAD, 517 cancer with 59 normal),
lung squamous cell carcinoma (LUSC, 501 cancer with 51 normal),
prostate adenocarcinoma (PRAD, 498 cancer with 52 normal),
stomach adenocarcinoma (STAD, 415 cancer with 35 normal), and
thyroid carcinoma (THCA, 509 cancer with 59 normal). The data links
for the TCGA raw data are available in Supplemental Data 2. The
illuminahiseq_rnaseqv2-RSEM_genes_normalized (MD5) was log2
transformed, and the relative transcript abundance of ACC1 (ACACA)
and ACC2 (ACACB) were compared using adjusted P-value (Benjamini–
Hochberg). For anunsupervisedhierarchical cluster analysis of ACC2 and
Snail transcripts, Ward linkage method was used together with the
Pearson distance for both sample and gene clustering. The statistical
significance of ACC2 and Snail transcript according to the p53mutational
status and cancer subtype was determined by Tukey’s HSD (honestly
significant difference) test. To generate Kaplan–Meier plots according to
ACC2 transcript abundance, clinical samples were grouped by p53
mutational status, and the plots were generated using the R package
survival.
Molecular modeling of CB83 compound and G6PD
Molecular docking calculations were performed using the AutoDock
4.2 programs to evaluate the binding mode of CB83 within a G6PD
substrate binding site (PDB code 2BHL, https://www.rcsb.org/
structure/2BHL) using an empirical free energy force field and
rapid Lamarckian genetic algorithm search method. The maximum
number of energy evaluations was set to 500,000, default values
being used for the other parameters. The Lamarckian genetic al-
gorithm was chosen to determine the best conformers in 50 in-
dependent trials of ligand. The lowest energy conformation in the
most populated of the first five clusters was used for docking pose
analysis. The structural figures were visualized using the PyMOL
program.
Xenograft and in vivo metastasis
All animal experiments were performed in accordance with the
Institutional Animal Care and Use Committee of the Yonsei Uni-
versity and approved by the Animal Care Committee of the Yonsei
University College of Dentistry and National Cancer Center Research
Institute. Female athymic nude mice (6 wk old) were used for
orthotopic xenograft assays into the mammary fat pads and lung
metastasis assay. For loss of function study with ACC2 over-
expression, MDA-MB-231 cells of control or experimental cells were
harvested with trypsin treatment and injected orthotopically into
the mammary fat pads (1 × 106 per 0.1 ml of PBS). The tumor ini-
tiating capacity was measured twice a week using a digital caliper
and the tumor volume was calculated with equation V (in mm3) = (a
× b2)/2, where a is the longest and b is the shortest diameter. For
lung metastasis assays, MDA-MB-231-luc-D3H2LN cells expressing
control vector or ACC2 were injected into the lateral tail vein, de-
tailed experimental conditions being described in each figure
legend. Lung colonization was monitored and quantified using
pathological examination at day 28. Mice were euthanized and
perfused with 4% paraformaldehyde, and lungs were extracted for
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paraffin-embedding. Paraffin-embedded sections were stained
with routine hematoxylin and eosin and the number of lung
metastatic nodules was counted under microscopic examination.
For pharmacologic inhibition of tumorigenesis and lungmetastasis,
mice received vehicle or 50mg/kg etomoxir dissolved in PBS (i.p.) or
100mg/kg of DHEA (p.o.) or combination of etomoxir and DHEA after
injection of MDA-MB-231 cells. The vehicle or drugs were admin-
istered five times a week for 3 wk for tumorigenesis and 4 wk for
lung metastasis assay.
Statistical analysis and reproducibility
All statistical analysis of reporter assay, RT-PCR, and soft agar assay
was performed with two-tailed t tests; data are expressed as means
and SD. The double asterisks denote P < 0.01, one asterisk denoting
P < 0.05. Statistical significance of animal experiments was de-
termined using the Mann–Whitney test. No statistical method was
used to predetermine sample size.
Data Availability
The data that support the findings of this study are available from
the corresponding author upon reasonable request.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
202000683.
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